Bloomfield, NJ, United States of America

Hanspeter Michel


 

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2016

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Hanspeter Michel

Introduction

Hanspeter Michel is a notable inventor based in Bloomfield, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of anticancer agents. His work has been recognized through the granting of a patent, showcasing his innovative spirit and dedication to advancing medical science.

Latest Patents

Hanspeter Michel holds a patent for "Substituted pyrrolidine-2-carboxamides." This patent includes compounds of a specific formula, wherein X, Y, Z, R, and R are defined as described in the patent documentation. The compounds are recognized for their potential use as anticancer agents, highlighting Michel's commitment to addressing critical health challenges.

Career Highlights

Throughout his career, Hanspeter Michel has worked with prominent companies in the pharmaceutical industry, including Hoffmann-La Roche Inc. and F. Hoffmann-La Roche AG. His experience in these organizations has allowed him to collaborate with leading experts and contribute to groundbreaking research in drug development.

Collaborations

Hanspeter Michel has had the opportunity to work alongside talented individuals such as David Joseph Bartkovitz and Xin-Jie Chu. These collaborations have enriched his research and contributed to the advancement of innovative solutions in the pharmaceutical field.

Conclusion

In summary, Hanspeter Michel is a distinguished inventor whose work in developing anticancer agents has made a significant impact in the pharmaceutical industry. His patent and collaborations reflect his dedication to innovation and improving healthcare outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…